Factors affecting continuous renal replacement therapy duration in critically ill patients: A retrospective study

Ther Apher Dial. 2023 Oct;27(5):898-908. doi: 10.1111/1744-9987.14024. Epub 2023 Jun 12.

Abstract

Introduction: This study aimed to analyze the factors affecting continuous renal replacement therapy (CRRT) duration in critically ill patients and provide a reference for clinical treatment.

Material and methods: We divided patients into regional citrate anti-coagulation (RCA) and low-molecular-weight-heparin (LMWH) groups according to the anti-coagulation method and collected the relevant data, to analyze the factors associated with CRRT time.

Results: Compared with the LMWH group, the RCA group had a longer mean treatment time (55.36 ± 22.57 vs. 37.65 ± 27.09 h, p < 0.001), lower transmembrane pressure, and lower filter pressure, regardless of vascular access site. Multivariable linear regression analysis showed a significant correlation between anti-coagulation patterns, filter pressure at CRRT discontinuation, nurses' level of intensive care unit experience, pre-machine fibrinogen level, and CRRT time.

Conclusion: Anti-coagulation is the most important factor affecting CRRT duration. Filter pressure, nurses' level of intensive care unit experience, and fibrinogen level also affecting CRRT duration.

Keywords: anticoagulants; citrate; intensive care unit; low molecular weight heparin; renal replacement therapy.

MeSH terms

  • Acute Kidney Injury* / therapy
  • Anticoagulants / adverse effects
  • Citrates
  • Citric Acid / adverse effects
  • Continuous Renal Replacement Therapy*
  • Critical Illness / therapy
  • Fibrinogen
  • Heparin
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Renal Replacement Therapy / methods
  • Retrospective Studies

Substances

  • Anticoagulants
  • Heparin
  • Heparin, Low-Molecular-Weight
  • Citric Acid
  • Citrates
  • Fibrinogen